Skip to main content

Table 1 Patients' responses per response category (Number and %) to each item of the questionnaire

From: Clinical trials in advanced stage lung cancer: a survey of patients' opinion about their treatmentTrial clinici nel tumore del polmone in stadio avanzato: un’analisi dell’opinione dei pazienti riguardo al trattamento

Question

Answers

  

Yes n/%

No n/%

I am not sure n/%

1.

Are you familiar with the nature of disease you suffer from?

59/100

0/0

0/0

2.

Do you know the type of lung cancer you suffer from?

50/84.7

0/0

9/15.3

3.

Do you know what kind of chemotherapy for lung cancer you received so far?

58/98.3

0/0

1/1.7

4.

Are you aware at what stage your condition (lung cancer) currently is?

44/74.6

1/1.7

14/23.7

5.

Have you received your previous chemotherapy in a regional hospital or at the Institute for Pulmonary Diseases of Vojvodina (IPBV)?*

58/98.3

0/0

1/1.7

6.

Do you understand that you are participating in a clinical trial with novel chemotherapy or a targeted therapy drug?

47/79.7

0/0

12/20.3

7.

Do you understand what a clinical trial is?

47/79.7

0/0

12/20.3

8.

Have you read the entire Informed Consent Form (ICF) your physician gave before you entered the clinical trial?

54/91.5

5/8.5

0/0

9.

How satisfied are you with the information about the clinical trial you obtained from your physician or from the ICF?*

   

10.

Do you think that during the clinical trial period you will need additional information about the study treatment?

28/47.5

29/49.2

2/3.4

11.

Do you think that by participating in a clinical trial you have a better chance for surviving the lung cancer?

55/93.2

0/0

4/6.8

12.

Do you think that chemotherapy given within the clinical trial is better than the chemotherapy patients usually get?

48/81.4

2/3.4

9/15.3

13.

Are you aware of the fact that you might not be treated with the investigational product in the clinical trial you are currently participating?

58/98.3

0/0

1/1.7

14.

Do you think that the investigational product (chemotherapy) given in the clinical trial you are currently participating in has fewer side effects than the chemotherapy you were previously treated with?

38/64.4

16/27.1

5/8.5

15.

Do you think that medical personnel (physicians and nurses) conducting this clinical trial have sufficient knowledge and training?

57/96.6

1/1.7

1/1.7

16.

Do you think that physicians and nurses are more easily accessible to you because you are participating in the clinical trial?

59/100

0/0

0/0

17.

Do you think that your treatment within the clinical trial is better than the treatment of patients who are not participating in clinical trials?

57/96.6

0/0

2/3.4

18.

How would you assess your treatment in the clinical trial so far?*

52/88.1

2/3.4

5/8.5

19.

If there would be an opportunity to join another clinical trial, after you finish the current one, would you join?

52/88.1

2/3.4

5/8.5

20.

Would you recommend to other patients to join the clinical trial you have been participating in?

56/94.9

1/1.7

2/3.4

  1. Answers on questions marked with asterisk are explained in the text.
  2. Questions are consecutively stated in Figure 1.